UCLA Intramural Parkinson’s Disease Research Symposium
Friday, July 17, 2020 - 12:00pm
Tuesday, July 7 @ 1:00 pm | Wednesday, July 8 @ 12:00 pm | Friday, July 17 @ 12:00 pm
This intramural symposium was designed to bring UCLA Parkinson’s disease (PD) researchers together to further synergize our efforts and make an even greater impact on PD. The event was originally designed as an in-person symposium but will now be held virtually over three days. We invite you to join us.
For non-speaker participants, please register using this link:
Webinar links will be provided upon registration.
For questions, please contact Nader Pouratian, MD, PhD at NPouratian@mednet.ucla.edu
MOLECULAR NEUROSCIENCE AND PHARMACOLOGY
Friday, July 17, 2020 | 12:00 pm – 2:30 pm
Friday, July 17, 2020 | 12:00 pm – 2:30 pm
| 12:00 p.m. | Welcome |
| 12:05 p.m. | Jose Rodriguez, PhD Probing the origin and spread of synuclein amyloids through structure-activity relationships |
| 12:20 p.m. | Gal Bitan, PhD α-Synuclein in CNS derived exosomes distinguishes Parkinson’s disease from multiple system atrophy |
| 12:35 p.m. | Ming Guo, MD, PhD Making Mitochondria Great Again - Mutations in PINK1 and Parkin |
| 12:50 p.m. | Discussion/Break |
| 1:05 p.m. | Wael El-Nachef, MD, PhD The “Second Brain” and Parkinson’s Disease |
| 1:20 p.m. | Lin Jiang, PhD Exploring the structure and pathogenic action of alpha-synuclein fibrils in PD |
| 1:35 p.m. | Varghese John, PhD Neutral sphingomyelinase 2 as a novel target for PD therapeutics development |
| 1:50 p.m. | Sally Frautschy, PhD Potential of aSyn-fibril-structure-based peptide inhibitor liganded to nanoparticles (LMNPs) as a MRI-based Biomarker and therapy for Parkinson’s Disease (PD) |
| 2:05 p.m. | Discussion/Break |
| 2:30 p.m. | End |
